Cell Culture Technology– category –
-
Century Therapeutics Unveils CNTY-813 iPSC-Derived Islet Replacement Preclinical Data at ADA 2026: Demonstrates Durable Glucose Control, Immune Evasion, and Scalable Manufacturing, IND Filing Expected Q4 2026
BioSpace (via GlobeNewswire) USA Overview Century Therapeutics presented new preclinical data for its iPSC-derived islet replacement therapy, CNTY-813, at the ADA 2026 Scientific Sessions. The data demonstrated durable glucose control, i... -
Preprint Reviews NKG2D CAR-NK Cell Progress in Cancer Immunotherapy: Low GVHD Risk, Scalable Manufacturing, and iPSC-Derived NK Cells as a Platform for Off-the-Shelf Therapies
Preprints.org International Overview A preprint on Preprints.org reviews recent progress in NKG2D CAR-NK cells for cancer immunotherapy, highlighting their favorable safety profile with rare instances of graft-versus-host disease (GVHD) ... -
MDPI Paper Analyzes Direct Cellular Reprogramming Advances and Challenges: Functional Transformation of Fibrotic Tissues vs. Safety and Efficiency Bottlenecks
MDPI Switzerland Overview A scholarly article in MDPI reviews advances in direct cellular reprogramming for regenerative medicine, highlighting its potential to transform fibrotic tissues into functional parenchyma. However, it criticall... -
Evotec Establishes GMP-Ready Automated 3D Stirred-Tank Bioprocess for iPSC-Derived Macrophages, Achieving Consistent Quality and High Yield
Evotec Germany Overview Evotec has announced the establishment of an automated, GMP-compliant 3D stirred-tank bioprocess for the scalable production of iPSC-derived macrophages. This innovative process suggests the capability to manufact... -
Cellares and TScan Therapeutics Partner to Automate Manufacturing of TCR-T Therapy Candidate TSC-101 for Hematologic Malignancies, Accelerating Commercialization
OTC Markets (BusinessWire) USA Overview Cellares and TScan Therapeutics announced an agreement to evaluate the automated manufacturing of TSC-101, a TCR-T cell therapy candidate for patients with hematologic malignancies. This collaborat... -
REPROCELL Standardizes and Streamlines PBMC Processing for Multi-Site Clinical Trials with Semi-Automated, Closed Systems and Fully Automated Microfluidic Platforms
REPROCELL Japan Overview A REPROCELL article addresses challenges in Peripheral Blood Mononuclear Cell (PBMC) processing for multi-site clinical trials by introducing innovative solutions to enhance efficiency and standardization. Improv... -
Bailun Identifies Eppendorf’s Versatile Bioreactor Portfolio Among Top 19 Lab Bioreactor Manufacturers in 2026
Bailun China Overview An article by Bailun, "Top 19 Lab Bioreactor Manufacturers in 2026," highlights Eppendorf's extensive bioprocess portfolio and diverse product range. Eppendorf offers scalable bioreactor systems, single-use and glas... -
Made Scientific and Pluristyx Strengthen Alliance for iPSC Cell Therapy Manufacturing, Aiming to Reduce Rework and Accelerate Development Timelines
Made Scientific USA Overview Made Scientific and Pluristyx announced an enhanced strategic partnership to accelerate the development of iPSC-derived cell therapy candidates. This collaboration integrates Pluristyx's advanced iPSC platfor... -
Cytiva Achieves Enhanced mAb Variant Separation and Purity Using IEX and Multimodal Resins, Optimizing Elution pH with Capto SP ImpRes
Cytiva USA Overview Cytiva's latest research demonstrates a significant improvement in separating charged monoclonal antibody (mAb) variants and achieving higher purity using ion exchange (IEX) and multimodal resins. Specifically, optimi... -
Next-Gen Process Analytics and QC Elevate Bioprocessing Efficiency: Real-Time Raman Probes Enable Continuous Glucose and Lactate Monitoring
Technology Networks UK Overview A Technology Networks article highlights how next-generation Process Analytical Technology (PAT) and industrial Quality Control (QC) testing significantly enhance biopharmaceutical manufacturing efficiency...
